Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery […]
Histogen Announces Completion of Dosing Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential […]
Galectin Therapeutics Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
NORCROSS, Ga., Sept. 10, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, […]
EbixCash Travels Emerges as the Leading Travel & Forex partner to Majority of the Franchises for IPL – Asia’s Largest Sporting Event in the Last 12 Months
NOIDA, India and JOHNS CREEK, Ga., Sept. 10, 2020 (GLOBE NEWSWIRE) — EbixCash, a fully owned subsidiary of Ebix, Inc. […]
Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
GDS Announces Partnership on Renewable Energy Initiatives
SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a […]
FuelCell Energy Reports Results for the Third Quarter of Fiscal 2020
Third Quarter Fiscal 2020 Highlights(All comparisons year-over-year unless otherwise noted)Revenues of $18.7 million compared to $22.7 millionOperating expenses decreased 16% […]
Check Point Software Technologies Named a Leader in the IDC MarketScape Report for Mobile Threat Management
SAN CARLOS, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of […]
Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China
– ZEJULA is the only PARP inhibitor approved as monotherapy for all-comer patients in the first-line and recurrent maintenance treatment […]
Huazhu Group Limited Launches Hong Kong Initial Public Offering
SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — Huazhu Group Limited (Nasdaq: HTHT), a leading and fast-growing multi-brand hotel group […]
